Abstract

Anemia frequently complicates the clinical scenario in patients with solid tumors. Intensified by the tumor’s metabolic demands, inflammation, and treatment regimens, anemia detrimentally impacts quality of life and clinical outcomes. This review delves into the multifaceted pathophysiology, including molecular and genetic insights, diagnostic approaches, contemporary management strategies, and therapeutic advancements. Emphasis is placed on translational research and emerging treatments.

Keywords

anemia, inflammation, síndrome, deficiency